| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $377K | -24.6% |
| Cost of Revenue | $100.0M | — |
| Gross Profit | $377K | +543.5% |
| R&D Expense | $11.5M | +23.3% |
| SG&A Expense | $21K | +0.0% |
| Operating Income | -$56.2M | -104.9% |
| Interest Expense | $659K | +0.0% |
| Pre-tax Income | -$56.2M | -100.1% |
| Net Income | -$56.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.5M | -58.1% |
| Accounts Receivable | $17K | -91.5% |
| Current Assets | $24.4M | -57.5% |
| Total Assets | $32.5M | -44.9% |
| Current Liabilities | $8.4M | +97.8% |
| Total Liabilities | $9.5M | +122.1% |
| Stockholders' Equity | $23.0M | -57.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.7M | -68.0% |
| Capital Expenditures | $3.2M | +271.2% |
| Investing Cash Flow | -$4.1M | -376.6% |
| Financing Cash Flow | $2.6M | -96.4% |
| Free Cash Flow | -$32.9M | -77.5% |
| -100.1% |
| EPS (Basic) | -$1.55 | -2.6% |